Tadao Ohno Selected Research

Alum Compounds

12/2017

Biodegradable Metal Ion-Doped Mesoporous Silica Nanospheres Stimulate Anticancer Th1 Immune Response in Vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tadao Ohno Research Topics

Disease

28	Neoplasms (Cancer) 01/2022 - 01/2003
6	Glioma (Gliomas) 01/2018 - 08/2003
6	Glioblastoma (Glioblastoma Multiforme) 06/2015 - 01/2006
5	Hepatocellular Carcinoma (Hepatoma) 06/2015 - 04/2002
3	Neoplasm Metastasis (Metastasis) 01/2018 - 06/2013
3	Breast Neoplasms (Breast Cancer) 01/2018 - 06/2013
3	Carcinoma (Carcinomatosis) 11/2017 - 10/2015
3	Lewis Lung Carcinoma 04/2014 - 01/2013
2	Gallbladder Neoplasms (Gallbladder Cancer) 09/2017 - 05/2004
1	Infections 12/2017
1	Pathologic Complete Response 11/2017
1	Lymphatic Metastasis 11/2017
1	Colonic Neoplasms (Colon Cancer) 09/2017
1	Small Cell Carcinoma 07/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2015
1	Fever (Fevers) 10/2013
1	Margins of Excision 08/2011
1	Erythema 08/2011
1	Werner Syndrome (Werner's Syndrome) 04/2005
1	Atherosclerosis 04/2005
1	Brain Neoplasms (Brain Tumor) 01/2004
1	Hypersensitivity (Allergy) 04/2002

Drug/Important Bio-Agent (IBA)

19	Cancer VaccinesIBA 01/2022 - 04/2002
16	Formaldehyde (Formol)FDA Link 01/2018 - 03/2004
10	Silicon Dioxide (Silica)FDA LinkGeneric 01/2022 - 06/2013
5	VaccinesIBA 01/2018 - 04/2002
5	Immunologic Adjuvants (Immunologic Adjuvant)IBA 12/2017 - 06/2013
3	Interleukin-2 (IL2)IBA 01/2022 - 04/2002
3	aluminum sulfate (alum)IBA 12/2017 - 07/2013
3	NitrogenIBA 04/2014 - 01/2013
2	AntigensIBA 01/2018 - 07/2016
2	ParaffinIBA 01/2018 - 08/2007
2	Temozolomide (Temodar)FDA LinkGeneric 09/2014 - 01/2011
2	Pathogen-Associated Molecular Pattern MoleculesIBA 04/2014 - 07/2013
2	Tuberculin (PPD)IBA 10/2013 - 06/2013
2	Proteins (Proteins, Gene)FDA Link 06/2013 - 01/2006
2	Biological ProductsIBA 02/2005 - 11/2003
2	CytokinesIBA 01/2003 - 04/2002
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Poly I-CIBA 01/2018
1	AluminumIBA 12/2017
1	Alum CompoundsIBA 12/2017
1	pembrolizumabIBA 07/2016
1	Aluminum Hydroxide (Algeldrate)FDA Link 01/2016
1	Carboplatin (JM8)FDA LinkGeneric 10/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2015
1	GlypicansIBA 06/2015
1	Protons (Proton)IBA 10/2013
1	Durapatite (Hydroxylapatite)IBA 10/2013
1	ApatitesIBA 07/2013
1	Fluorouracil (Carac)FDA LinkGeneric 06/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2013
1	Zoledronic Acid (Zometa)FDA Link 06/2013
1	Epirubicin (Ellence)FDA LinkGeneric 06/2013
1	Aromatase InhibitorsIBA 06/2013
1	calcium phosphateIBA 06/2013
1	4-trifluoromethylsalicylic acid (HTB)IBA 01/2013
1	N-(3,4,5-trichlorophenyl)succinimideIBA 01/2013
1	Phosphates (Orthophosphate)IBA 01/2013
1	Alkylating AgentsIBA 01/2011
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2006
1	HLA-A*02:01 antigenIBA 01/2006
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2006
1	Peptides (Polypeptides)IBA 01/2006
1	CholesterolIBA 04/2005
1	Interferon-alpha (Interferon Alfa)IBA 12/2004
1	HLA-DR Antigens (HLA-DR)IBA 08/2004
1	Surface Antigens (Surface Antigen)IBA 08/2004
1	paraform (paraformaldehyde)IBA 01/2004
1	Therapeutic UsesIBA 01/2004
1	Endothelial Growth FactorsIBA 11/2003
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2003
1	Thymidylate SynthaseIBA 11/2003
1	Thymidine PhosphorylaseIBA 11/2003
1	Interleukin-1 (Interleukin 1)IBA 08/2003
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2002

Therapy/Procedure

16	Therapeutics 01/2022 - 08/2003
13	Immunotherapy 01/2022 - 01/2012
5	Radiotherapy 09/2014 - 08/2011
4	Nanospheres 01/2018 - 01/2016
1	Injections 10/2013
1	Mastectomy (Mammectomy) 06/2013
1	Adjuvant Chemotherapy 06/2013
1	Drug Therapy (Chemotherapy) 01/2012
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2012
1	Adjuvant Radiotherapy 08/2011
1	Salvage Therapy 08/2011